ObjectiveTo investigate the efficacy of vinpocetine combined with danhong injection and its impact on neurologic function in patients with acute cerebral infarction. MethodsFrom January 2013 to January 2014, 100 hospitalized patients with acute cerebral infarction were selected and randomly divided into observation group and control group with 50 patients in each. Both groups were given conventional treatments. Patients in the control group were added with Vinpocetine, while patients in the observation group with both vinpocetine and danhong injection. The clinical efficacy of the two groups and the changes of NIHSS score, plasma viscosity, red blood cell hematocrit, and fibrinogen level before and after treatment were observed. ResultsThe total effective rates of the observation group and the control group were 96% and 78.0%, respectively (P＜0.01). There were significant differences between the two groups(P＜0.05). The clinical efficacy of the observation group was superior to that of the control group (P＜0.01). After treatment, the NIHSS scores of the observation group were greatly lower than that of the control group, which had significant differences. The plasma viscosity, red cell pressure volume, and fibrinogen level of the both groups decreased obviously after treatment, especially in the observation group, and there were significant differences between the two groups (P＜0.01). ConclusionsVinpocetine combined with danhong can improve the efficacy, promote the recovery of neurological function, and reduce the blood viscosity of acute cerebral infarction, which is worthy of clinical promotion.

• ref